Navigation Links
Global biotech firm partners with CHEO researcher to address a technology gap in infectious disease
Date:10/3/2011

OTTAWA, ON October 3, 2011 The Children's Hospital of Eastern Ontario (CHEO) Research Institute is pleased to announce that one of its principal investigators in infectious disease has signed a contract with Life Technologies, an internationally renowned biotech tools company headquartered in Carlsbad, California, to share information that will help to develop tests that uniquely amplify and detect the DNA coding for infectious diseases. Dr. Robert Slinger will focus on bacteria that cause severe infectious diseases.

"I believe Life Technologies to be a leader in its field, so it was an honor to be approached about contributing to this project," said Dr. Slinger, a CHEO Medical Microbiologist and Pediatric Infectious Diseases physician. "Life Technologies is one of the only companies in the world that has the full suite of technology to look at detection of infectious disease agents from extracting DNA and RNA from a sample to amplifying and detecting the results. I think they're ahead of the curve yet again, by bringing microbial testing to their innovation roadmap."

Dr. Slinger and Life Technologies are partnering with the objective to co-develop microbial detection tests. In short, they will identify the unique DNA sequence of targeted infectious disease pathogens which will ultimately be used to create tests that will rapidly and clearly indicate when a targeted infectious agent has been identified in a patient sample. Samples will be tested with "all-inclusive" panels that include tests for large numbers (e.g. 30-50) of infectious agents. This approach will ensure that all possible causes of the patient's infection are looked for at the same time, which Dr. Slinger believes will ultimately lead to better antibiotic treatment for patients.

"Dr. Slinger is well known as one of the first to use molecular panel technology to test for infectious disease in humans," said Astrid Ferlinz, Life Technologies' Global Market Development Manager, Darmstadt, Germany. "We're now embarking on a strategic partnership with Dr. Slinger that will one day alter how we look for infectious disease to help patients; but also to protect the public from contracting serious infections that can't be detected by current lab methods (for instance, consider the E. coli outbreak in Germany this spring)."


'/>"/>

Contact: Adrienne Vienneau
avienneau@cheo.on.ca
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. International Diabetes Federation awards $2 million to 9 global diabetes research projects
3. Virtual Global Highlights Top Ten Misconceptions about Cloud Computing
4. Global Health Defined as Public Health in a New Lancet Commentary by the Association of Schools of Public Health (ASPH)
5. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
6. Bioniche Achieves Two Additional Milestones Under Licensing Agreement; Endo Takes up Global Rights
7. Now Serving 9 Billion: A Global Town Hall
8. The Global Leaders' Inaugural Meeting a Resounding Success
9. Language Service Leader Expands to Meet Booming, Global Industry Demand.
10. GenomeQuest Hosts Seminar Focused On Web-based Searching for Patent Information Across Global Sequence Databases
11. Global Nutrition Firm Takes Dose of SonicWALL to Boost Network Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: